Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Amer H. Zureikat"'
Autor:
Alessandro Paniccia, Nathan Bahary, David L Bartlett, Kenneth K. Lee, Kenneth J. Smith, Amer H. Zureikat, Caroline J. Rieser, Sowmya Narayanan
Publikováno v:
J Surg Oncol
INTRODUCTION: Neoadjuvant therapy (NAT) is an emerging strategy for operable pancreatic ductal adenocarcinoma (PDAC). While neoadjuvant therapy increases multimodal therapy completion, it risks functional decline and treatment drop out. We used decis
Autor:
Caroline J. Rieser, Richard S. Hoehn, Mazen Zenati, Lauren B. Hall, Eliza Kang, Amer H. Zureikat, Andrew Lee, Melanie Ongchin, Matthew P. Holtzman, James F. Pingpank, David L. Bartlett, M. Haroon A. Choudry
Publikováno v:
Annals of Surgical Oncology
Ann Surg Oncol
Ann Surg Oncol
Background Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion (CRS HIPEC) can offer significant survival advantage for select patients with colorectal peritoneal metastases (CRPM). Low socioeconomic status (SES) is implicated in di
Autor:
A. Floortje van Oosten, Michael J. Pflüger, Wenjie Huang, Elizabeth D. Thompson, Vincent P. Groot, Steven Gallinger, Sandra Fischer, Limin Xia, Neil M. Neumann, Nicholas J. Roberts, Richard A. Burkhart, Stefan Heinrich, Alina Hasanain, Claudio Luchini, Jin He, Kim-Vy Nguyen-Ngoc, Bernat Navarro-Serer, Anne Macgregor-Das, Laura D. Wood, Maria A. Trujillo, Gemma Lionheart, Andrew J. Ewald, Peter Chianchiano, Michael Goggins, Amer H. Zureikat, Christopher L. Wolfgang, Randall E. Brand, Yea Ji Jeong, Matthias M. Gaida, Cameron Dowiak, Tammy Ng, Aatur D. Singhi, Danielle Jones, Kohei Fujikura, Bo Huang, Nicola Veronese
Publikováno v:
Cancer Res
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by extensive local invasion and systemic spread. In this study, we employed a three-dimensional organoid model of human pancreatic cancer to characterize the molecular
Autor:
Andrew Lee, James F. Pingpank, Matthew P. Holtzman, Shannon Altpeter, Melanie Ongchin, Caroline J. Rieser, David L Bartlett, M. Haroon A. Choudry, Amer H. Zureikat, Lauren B Hall, Eliza Kang, Heather Jones
Publikováno v:
Ann Surg Oncol
INTRODUCTION: Early recurrence (ER) is a significant challenge for patients with colorectal peritoneal metastases (CRPM) following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS HIPEC). Preoperative risk stratification for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c35eb5532ddc82a4bef8b9c86688e0e8
https://europepmc.org/articles/PMC8666126/
https://europepmc.org/articles/PMC8666126/
Autor:
Caroline J, Rieser, Jurgis, Alvikas, Heather, Phelos, Lauren B, Hall, Amer H, Zureikat, Andrew, Lee, Melanie, Ongchin, Matthew P, Holtzman, James F, Pingpank, David L, Bartlett, M Haroon A, Choudry
Publikováno v:
Annals of surgical oncology. 29(4)
Failure to thrive (FTT) is a complex syndrome of nutritional failure and functional decline. Readmission for FTT following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS HIPEC) is common but underexamined. This study aims to
Autor:
Caroline J. Rieser, David L. Bartlett, Asmita Chopra, Kenneth K.W. Lee, Sowmya Narayanan, Amer H. Zureikat, Alessandro Paniccia, Samer AlMasri, Tracy Daum, Mazen S. Zenati, Katelyn Smith, Nathan Bahary, Vivianne Oyefusi, Ibrahim Nassour
Publikováno v:
J Surg Oncol
BACKGROUND AND OBJECTIVES Neoadjuvant chemotherapy (NAT) for pancreatic adenocarcinoma (PDAC) is increasingly being utilized. However, a significant number of patients will experience early recurrence, possibly negating the benefit of surgery. We aim
Autor:
Samer S, AlMasri, Alessandro, Paniccia, Abdulrahman Y, Hammad, Reetesh K, Pai, Nathan, Bahary, Amer H, Zureikat, David S, Medich, James P, Celebrezze, Haroon A, Choudry, Ibrahim, Nassour
Publikováno v:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 26(1)
Appendiceal adenocarcinoma (AA) represents a heterogenous group of neoplasms with distinct histologic features. The role and efficacy of adjuvant chemotherapy (AC) in non-metastatic disease remain controversial. The aim of this study was to ascertain
Autor:
Melissa E. Hogg, Amir A. Borhani, Herbert J. Zeh, Juliana Tobler, Ahmad Hamad, Mazen S. Zenati, Amer H. Zureikat, Patrick R. Varley, A. Klobuka
Publikováno v:
HPB. 21:695-701
We sought to investigate whether robotic pancreatoduodenectomy (RPD) mitigates adverse outcomes in patients with high-risk morphometric features compared to the open approach (OPD).Morphometric parameters for RPD and OPDs were measured by two blinded
Autor:
Amr Al-abbas, Melissa E. Hogg, Caroline J. Rieser, Matthew D. Neal, Amer H. Zureikat, Mazen S. Zenati, Brian A. Boone, Ahmad Hamad, Herbert J. Zeh
Publikováno v:
Annals of Surgical Oncology. 26:1503-1511
Pancreatic ductal adenocarcinoma (PDA) is associated with a hypercoagulable state, resulting in a high risk of venous thromboembolism (VTE). Risk of VTE is well established for patients receiving chemotherapy for advanced disease and during the perio
Autor:
Samer Tohme, Sidrah Khan, Alison Althans, Maria Mascara, Richard S. Hoehn, Ibrahim Nassour, Amer H. Zureikat, Christof Kaltenmeier
Publikováno v:
Am Surg
Introduction With advances in multimodal therapy, survival rates in gastric cancer have significantly improved over the last two decades. Neoadjuvant therapy increases the likelihood of achieving negative margins and may even lead to pathologic compl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1ef003a121bec2ea08cc15d38edf601
https://europepmc.org/articles/PMC8213860/
https://europepmc.org/articles/PMC8213860/